Enlivex Therapeutics (Israel) Today
| ENLV Stock | ILA 372.90 4.90 1.33% |
Performance0 of 100
| Odds Of DistressLess than 36
|
Enlivex Therapeutics is trading at 372.90 as of the 26th of November 2024, a 1.33 percent increase since the beginning of the trading day. The stock's open price was 368.0. Enlivex Therapeutics has about a 36 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Enlivex Therapeutics are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 7th of December 2022 and ending today, the 26th of November 2024. Click here to learn more.
Enlivex Therapeutics Ltd. operates as a clinical stage immunotherapy company. Enlivex Therapeutics Ltd. was incorporated in 2005 and is headquartered in Nes Ziona, Israel. ENLIVEX THERAPEUTI operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. The company has 18.41 M outstanding shares. More on Enlivex Therapeutics
Moving against Enlivex Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Enlivex Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Enlivex Therapeutics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Enlivex Therapeutics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Dror Mevorach |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Enlivex Therapeutics (ENLV) is traded on Tel Aviv Stock Exchange in Israel and employs 71 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 273.23 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Enlivex Therapeutics's market, we take the total number of its shares issued and multiply it by Enlivex Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Enlivex Therapeutics operates under Healthcare sector and is part of Biotechnology industry. The entity has 18.41 M outstanding shares.
Enlivex Therapeutics has accumulated about 90.6 M in cash with (17.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.95.
Check Enlivex Therapeutics Probability Of Bankruptcy
Ownership AllocationEnlivex Therapeutics holds a total of 18.41 Million outstanding shares. Enlivex Therapeutics shows 12.19 percent of its outstanding shares held by insiders and 9.53 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Enlivex Ownership Details
Enlivex Therapeutics Risk Profiles
Although Enlivex Therapeutics' alpha and beta are two of the key measurements used to evaluate Enlivex Therapeutics' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.87 | |||
| Standard Deviation | 4.09 | |||
| Variance | 16.69 | |||
| Risk Adjusted Performance | (0.07) |
Enlivex Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Enlivex Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sectors Now
SectorsList of equity sectors categorizing publicly traded companies based on their primary business activities |
| All Next | Launch Module |
Enlivex Therapeutics Corporate Executives
Elected by the shareholders, the Enlivex Therapeutics' board of directors comprises two types of representatives: Enlivex Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Enlivex. The board's role is to monitor Enlivex Therapeutics' management team and ensure that shareholders' interests are well served. Enlivex Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Enlivex Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Shachar Shlosberger | Chief Financial Officer | Profile |
Additional Information and Resources on Investing in Enlivex Stock
When determining whether Enlivex Therapeutics is a strong investment it is important to analyze Enlivex Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Enlivex Therapeutics' future performance. For an informed investment choice regarding Enlivex Stock, refer to the following important reports:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enlivex Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Enlivex Stock refer to our How to Trade Enlivex Stock guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.